In a guest post on the GlobalPost’s “Global Pulse” blog, Janet Fleischman, a senior associate at the CSIS Global Health Policy Center, describes the Malawian government’s “plans to launch a ‘test and treat’ program in which all HIV-infected pregnant women will immediately be put on antiretroviral treatment (ART) drugs for life.” But she adds that “[t]he growing political and economic crisis in Malawi, highlighted by the government’s use of force against peaceful demonstrators last week, could also imperil the groundbreaking expansion of Malawi’s national HIV/AIDS program.”

“The implementation of Malawi’s new strategy faces many challenges,” but “the new approach also presents opportunities to address HIV/AIDS in Malawi,” she writes. “It is not clear what impact [the political and economic situation] will have on the relationship between the government of Malawi and its key international donors,” Fleischman says, concluding, “What is clear is that Malawi cannot hope to achieve its new HIV/AIDS targets without significant international support” (7/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.